Results 51 to 60 of about 2,846 (197)
Cilengitide activates αVβ3 on HUVEC.
(a) HUVEC in suspension were exposed to 10 µM of cilengitide or EMD135981 for 10 minutes, stained by immunofluorescence for β3 LIBS and total αVβ3 expression (with LIBS-1 and LM609 mAbs, respectively) and analyzed by flow cytometry.
Gian Carlo Alghisi (374631) +2 more
core +1 more source
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial [PDF]
Background Cilengitide is a selective alpha v beta 3 and alpha v beta 5 integrin inhibitor. Data from phase 2 trials suggest that it has antitumour activity as a single agent in recurrent glioblastoma and in combination with standard temozolomide ...
Schnell, Oliver +36 more
core +3 more sources
Lighting up αVβ6: Halotryptophan engineering converts an RGD scaffold into a modular αVβ6 ligand platform, enabling picomolar affinity and late‐stage functionalization. The resulting probes combine high selectivity with fluorescence for FACS and tumor imaging.
Beate Nachtigall +4 more
wiley +1 more source
Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models [PDF]
Integrins are expressed in tumor cells and tumor endothelial cells, and likely play important roles in glioma angiogenesis and invasion. We investigated the anti-glioma mechanisms of cilengitide (EMD121974), an v3 integrin inhibitor, utilizing the novel ...
Onishi, Manabu +9 more
core +1 more source
Cilengitide induces VE-cadherin loss form cellular junctions.
(a) Confluent HUVEC plated on fibronectin, were exposed to cilengitide or EMD135981 (10 µM each) or VEGF (100 ng/ml) for 20 minutes and stained for VE-cadherin.
Gian Carlo Alghisi (374631) +2 more
core +1 more source
Objective: Cellular senescence halts the proliferation of damaged or preneoplastic cells, playing a vital role in cancer control. In HER2-positive breast cancer, resistance to trastuzumab, a HER2-targeted monoclonal antibody, remains a significant ...
Asiye Büşra Boz Er, İdris Er
doaj +1 more source
The vascular barrier is heavily injured following SARS-CoV-2 infection and contributes enormously to life-threatening complications in COVID-19. This endothelial dysfunction is associated with the phlogistic phenomenon of cytokine storms, thrombotic ...
Danielle Nader, Steve W. Kerrigan
doaj +1 more source
Cilengitide causes detachment of MPM cells in monolayer culture.
Cells were allowed to adhere to tissue culture surface before incubation with 0, 1, or 10 µM cilengitide (CGT). Images were captured with the Zeiss Axiovert inverted microscope 1 day post-cilengitide treatment.
Glen Reid (207229) +2 more
core +1 more source
HER2-positive breast cancer has an aggressive tumour progression among breast cancers characterized by the overexpression of HER2. Trastuzumab is an FDA-approved drug and has significantly improved outcomes for patients; however, drug resistance remains ...
Asiye Busra Boz Er
doaj +1 more source
Background To date the TGF-β1 activation mediated by integrin ανβ5 during fibrosis is well-known. This process has been shown also in the heart, where cardiac fibroblasts (CF) differentiate into α-smooth muscle actin (α-SMA)-positive myofibroblasts ...
Gianluca Lorenzo Perrucci +9 more
doaj +1 more source

